Q2 2025 Earnings Call February 4, 2025 8:00 AM ETCompany ParticipantsBen Krasinski - Senior Director, IRMichael J.

Reports Q4 revenue $521M, consensus $518.54M. The company said, “Our solid sales growth in the second half of 2024 mirrors our plans for ...

Reports Q4 revenue $9.7B, consensus $9.44B. “2024 was a remarkable year for PMI. We delivered very strong full-year results driven by the ...

Hansa Biopharma AB, Hansa or the Company (Nasdaq Stockholm: HNSA) today announced its full year and Q4 2024 financial results. Søren ...

Here Are Other Stocks Moving In Monday's Mid-Day Session Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for ...

IDEFIRIX Product Sales Increased 83% Compared to the Prior Year LUND, Sweden, Feb. 6, 2025 /PRNewswire/ -- Hansa Biopharma AB, Hansa or the Company (Nasdaq Stockholm: HNSA) today announced ...

Here's a look at the details from the report: Erica Kollmann Ardelyx Files Lawsuit Over Medicare Drug Payment Rules, Claims It Will Limit Patient Access To Kidney Disease Treatment Ardelyx ...

Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...

Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...

Melissa Gilbert Says 'Little House On The Prairie' Reboot At Netflix "Will Do Things We Didn't Get To Do So Easily In '70s" ...

This leaflet answers some common questions about DAPA-TABS. It is not to be used in relation to any other product, which may also contain the same active ingredient. It does not contain all of the ...

This leaflet answers some common questions about COSAMIDE 50. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines ...